Faber Daeufer Itrato & Cabot is comprised of professionals whose collective experience handling life science business transactions and in-house operational knowledge are extraordinary in a law firm.
Our significant focus on the drug and life sciences industries has led us to the assembly of a professional staff of resident experts. Our professionals provide a unique combination of substantive legal expertise and business strategy leadership developed through years of working in life sciences businesses, venture capital firms and licensing offices of academic research institutions. Nearly all of our senior professionals have worked in-house in a management role in organizations similar to our clients. Among our principals, one has served as Chief Executive Officer of a drug development company and another has led the business development efforts of a platform technology company. Other Firm principals have run in-house legal departments or practice groups at biotechnology companies. Several of our contracts specialists have directed the contracts administration function at pharmaceutical and biotechnology companies, hospitals and academic research institutions.
Deep Experience Meeting Emerging Technology Company Needs
Our team has deep experience counseling entrepreneurs and mature companies that have technology-based businesses, from idea inception through commercialization and strategic partnerships or exits, in areas such as cleantech, cloud computing, software as a service, internet, mobile and others.
As a team we have worked on angel, venture and strategic financings valued in the hundreds of millions, as well as mergers and acquisitions valued in the billions. As a result, we are constantly considering the implication of our advice and our clients’ business decisions on their future financing, strategic and liquidity transactions.Lawyers